Filter Results:
(232)
Show Results For
- All HBS Web
(232)
- News (73)
- Research (134)
- Events (1)
- Multimedia (3)
- Faculty Publications (95)
Show Results For
- All HBS Web
(232)
- News (73)
- Research (134)
- Events (1)
- Multimedia (3)
- Faculty Publications (95)
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
out how to get into a clinical trial to try an experimental drug. For their part, physicians are often befuddled by difficult cases that don't respond to traditional therapies. And pharmaceutical companies,... View Details
- 19 Apr 2016
- News
LuminOva Makes Great Strides Tackling Infertility
towards commercialization. While many businesses enter the Challenge each year and benefit from the mentoring, workshops, and judging process, the winner of the Bertarelli Foundation Grand Prize receives a $40,000 award that moves the firm forward and helps it overcome... View Details
- 28 Feb 2020
- News
Filling the White Space
companies involved in research into psychedelic compounds for medical use. (Compass has been granted a US patent that covers a method of obtaining psilocybin to treat drug-resistant depression; the treatment is in a phase IIb clinical... View Details
- 20 Aug 2014
- News
With No Time to Lose
developed a way to measure electrical impulses in muscle tissue, and therefore measure changes in those impulses as the disease progresses. This one achievement can effectively reduce some costs associated with clinical View Details
Keywords: Margie Kelley
- Web
THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement
Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS... View Details
- 02 Aug 2011
- News
A Fearless Force for Change
founded with her husband Dave Linn (MBA '00) to fund research and clinical trials at Memorial Sloan-Kettering Cancer Center. Linn died July 20 at the age of 40. Diagnosed with a soft-tissue sarcoma (a... View Details
- 25 Apr 2014
- News
Bringing a new funding model to the life sciences industry
health care. "It's essentially a form of equity crowdfunding," Farquharson explains. "Since our focus is on breakthroughs in health care, success translates to dramatic improvements in clinical outcomes." Among those companies benefitting... View Details
- 01 Dec 2005
- News
Pedal Mettle
player who was diagnosed with Hodgkin’s disease in 1995, Berté saw the cancer return six months after she completed her initial treatment. She then enrolled in a clinical trial including chemotherapy,... View Details
- 08 Jun 2021
- News
New Funding for Female Founders
Boost VC, SV Angel, Village Global, and Threshold Ventures, according to the Wall Street Journal. Coravos is co-founder and CEO of the startup, formerly known as Elektra Labs, which helps hospitals and pharmaceutical companies employ sensor technologies to move medical... View Details
- Web
Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement
Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
early detection of gynecological diseases. The Oakland-based company completed its second clinical trial and is now raising Series A funding. Its initial indications focus on identifying conditions that... View Details
Keywords: Jen McFarland Flint
- 01 Dec 2013
- News
Innovation as Antidote
inspiration typically comes from a very human place. DART Therapeutics CEO Gene Williams (MBA 1987) ("Your Own Medicine"), for instance, told us about a revelation he had during a 2002 trip to Rotterdam to observe clinical View Details
Keywords: Health, Social Assistance
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
the anatomical—basis of the disease." Genzyme, which currently has drugs in clinical trials for melanoma and breast cancer, hopes to have its first products on the market as early as 2004. "I think... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
ask their scientists about therapeutics they are developing as their companies grapple with both clinical trial successes and failures. Classes also will focus on the most promising advances, including... View Details
Keywords: Jennifer Gillespie
- 09 Feb 2010
- First Look
First Look: Feb. 9
human patients. Doyle believes NovoCure has the potential to become an important company with a major new cancer therapy platform but must complete pivotal (Phase III) clinical trials and receive FDA... View Details
Keywords: Martha Lagace
- 19 Jun 2019
- News
Connecting Patients and Providers
traveled around the world for 20-minute appointments, but they had received vital advice from specialists in Turin, Helsinki, and Tokyo, where an applicable clinical trial was underway, via the internet.... View Details
Keywords: April White
- 01 Dec 2013
- News
Your Own Medicine
genome. Diagnosed with ALS (Lou Gehrig's disease) while at HBS, Avi Kremer (MBA 2007) and several of his classmates established Prize4Life, which offers awards to incentivize ALS research. Last year, the nonprofit also unveiled a revolutionary open-source ALS View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
antibiotic susceptibility profiles. The expertise DZD has developed along its three-year journey is already being deployed in clinical settings. “Our goal has always been to be commercially relevant, even during our R&D phase,” notes Lee.... View Details
Keywords: Susan Young
- 10 Nov 2020
- News
Learning to Fight
Eventually, he found a treatment trial at the Mayo Clinic that was testing a new combination of chemotherapy and high-dose radiation. Slowly, Susan’s tumor began to shrink, until there was nothing left but... View Details
Keywords: April White
- 01 Jun 2000
- News
The Business of Biotech
currently has drugs in clinical trials for mela-noma and breast cancer, hopes to have its first products on the market as early as 2004. "I think we're going to see more people in the next decade who are... View Details
Keywords: Julia Hanna